Cargando…
Over-expansion of drug-eluting stents in patients with left main coronary artery disease: An in vivo study
OBJECTIVE: We aimed to determine the capacity of drug-eluting stent (DES) over-expansion in left main coronary artery disease. METHODS: Left main interventions with the largest available DES platforms (4.0 mm) and post-dilation performed with large non-compliant balloons (≥ 4.5 mm) were included. Ma...
Autores principales: | Ye, Yicong, Qian, Hao, Yang, Ming, Zhu, Xueqing, Gan, Tianpeng, Zhang, Shuyang, Zeng, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625525/ https://www.ncbi.nlm.nih.gov/pubmed/28606023 http://dx.doi.org/10.1177/0300060517708515 |
Ejemplares similares
-
Drug‐Eluting or Bare‐Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization
por: Piccolo, Raffaele, et al.
Publicado: (2021) -
Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
por: Wang, Xiao-Zeng, et al.
Publicado: (2015) -
Percutaneous treatment of spontaneous left main coronary artery dissection using drug-eluting stent
por: Graidis, Christos, et al.
Publicado: (2014) -
Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound: A meta-analysis
por: Ye, Yicong, et al.
Publicado: (2017) -
Percutaneous coronary intervention versus cardiac bypass surgery for left main coronary artery disease: A trial sequential analysis
por: Ye, Yicong, et al.
Publicado: (2017)